You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial

Article metrics

Article menu

Download PDFPDF

Research Article
Progression-free and overall survival in ovarian cancer patients treated with CVac, a mucin 1 dendritic cell therapy in a randomized phase 2 trial

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019220
Jan 2020661
Feb 2020995
Mar 202022222
Apr 202016161
May 202025251
Jun 202071714
Jul 202029292
Aug 202018181
Sep 202043435
Oct 202045451
Nov 202031312
Dec 202038383
Jan 202143434
Feb 2021606113
Mar 202170703
Apr 202145458
May 202137376
Jun 202130304
Jul 202128282
Aug 202126267
Sep 202123235
Oct 202118182
Nov 2021403924
Dec 202133357
Jan 202228313
Feb 202225317
Mar 202231338
Apr 202238394
May 202251521
Jun 202250534
Jul 202256585
Aug 202266682
Sep 202266689
Oct 202240402
Nov 2022303211
Dec 202236366
Jan 202329293
Feb 202336363
Mar 2023606310
Apr 2023363717
May 202330308
Jun 202323233
Jul 202331329
Aug 202323232
Sep 202327274
Oct 202353535
Nov 20236316316
Dec 2023146814682
Jan 2024126212644
Feb 2024105810583
Mar 20241578158714
Total76707712268